NCT03993639View on ClinicalTrials.gov

KRN125 for Mobilization of Hematopoietic Stem Cells

PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

May 28, 2019

Primary Completion Date

July 21, 2020

Study Completion Date

August 28, 2020

Conditions
Peripheral Blood Stem Cell Transplantation
Interventions
DRUG

Pegfilgrastim

Single dose of SC administration

Trial Locations (1)

Unknown

Hokkaido University Hospital, Sapporo

All Listed Sponsors
lead

Kyowa Kirin Co., Ltd.

INDUSTRY

NCT03993639 - KRN125 for Mobilization of Hematopoietic Stem Cells | Biotech Hunter | Biotech Hunter